ad

Astec LifeSciences Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here

Posted by : sachet | Thu Jan 29 2026

Astec LifeSciences Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Astec LifeSciences’ Q3 results FY26 are scheduled to be announced on 30th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Astec LifeSciences Q3 Results 2026 Preview

  • Astec LifeSciences’ revenue is expected to be in the range of ₹93.86 crore, a 4.76% YoY decrease. 
  • Profit After Tax, or PAT, is projected to rise by 4.73% YoY. 
  • Astec LifeSciences’ EBITDA is expected to fall to ₹17.14 crore. 
  • Net profit is ₹4.38 crore, a rise 4.73% YoY 

Astec LifeSciences Share Performance 

  • Over the past six months, Astec LifeSciences’ share price has fallen by 34.13% to ₹574.20.
  • Moreover, over the past year, the stock has decreased by 43.07%.
  • Despite this weak short-term performance, Astec LifeSciences’ stock has delivered a financially sound 44.40% return over the past 5 years.
  • As of 30th January 2026, the stock traded at ₹574.30 per share.

Key Factors to Watch for Astec LifeSciences Q3 Results FY26

  • Revenue trend and segment performance, particularly in Enterprise and CDMO businesses.
  • Profitability and EBITDA trajectory, including narrowing losses or a return to profit.
  • Cost and margin dynamics are affected by raw materials, energy, and operating expenses.
  • Volume growth and price realisations for key agrochemical products.
  • Cash flow and balance sheet health, including debt levels and operating cash generation.

Final Thoughts

Astec LifeSciences will announce its Q3 FY26 results on 30th January 2026. Analysts expect 4.76% YoY revenue growth, a 4.73% rise in PAT, and a 45.06% fall in EBITDA. Astec LifeSciences focuses on agrochemical product volumes, CDMO growth, margin improvement, cost control, and strengthening cash flow and balance sheet health. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here